Westrock Coffee Missed. The Cash-Flow Inflection Did Not.

Westrock Coffee reported a wider-than-expected loss last week. Adjusted EPS came in at a $0.14 loss versus a $0.12 consensus, and second-quarter revenue of $306 million fell short of the roughly $319 million analysts expected. The stock dropped nearly 10 percent on the news, and the tape noise has been loud enough to drown out the rest of the quarter.

The market is still pricing the old story — a loss-making builder that can't hit its per-share estimates. The numbers from the quarter underneath the headline say something different.

The proof point: capex collapse meets EBITDA acceleration

Westrock's adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash earnings — hit a second-quarter record of $21.3 million, up 39 percent from a year earlier. That is the fifth consecutive quarter of year-over-year EBITDA growth. First-half EBITDA was $47.3 million, more than double the $23.5 million from the same period in 2025.

The bigger structural change is on the spending side. Second-quarter capital expenditures were $6.5 million, down from over $20 million in the same quarter last year. Full-year 2026 capex is expected to land near $30 million. That is down from $89 million in 2025 and $160 million in 2024. Going forward, management expects maintenance capex to run around $15 million — roughly half the current level.

The Conway manufacturing expansion, which drove the multi-quarter capex surge, is now fully commercialized. The heavy investment phase is behind the company. Management put it plainly: they've transitioned from a capital-intensive builder to a cash-generating platform.

What happens when you combine the two

When EBITDA is accelerating and capex is collapsing, free cash flow is the bridge between them. Westrock generated $20.2 million in free cash flow in the second quarter, turning positive a quarter ahead of schedule. The company had been burning cash through the Conway buildout. Now it is producing it.

Free cash flow is the hard proof. It does not care about adjusted versus GAAP accounting, or whether a per-share loss was $0.14 or $0.12. The question is whether the business can generate cash after the lights are paid and the equipment is bought. The answer this quarter was yes.

The net loss narrowed to $13.7 million from $21.6 million a year ago. Operating loss compressed to $1.4 million from $15 million. On a half-year basis, operating income was positive versus a $28 million loss in the first half of 2025. These are not cosmetic improvements — they are the operating leverage you expect when a facility ramps up and fixed costs stop growing.

Why the miss still stung

The revenue miss matters. $306 million versus roughly $319 million is about a 4 percent shortfall. Gross profit declined $3.6 million year-over-year, dragged down by $4.1 million in incremental depreciation from Conway and a $2 million mark-to-market hit in the single-serve cups segment. And the company still carries roughly $840 million in debt, though net leverage has improved to 3.36 times for the fifth straight quarter.

The stock is also up roughly 79 percent year-to-date before this week's pullback. A lot of the inflection narrative was already priced in. The miss was a reality check for a tape that had run hard.

But the operating trajectory underneath the miss has not reversed. First-half revenue of approximately $614 million was up 24 percent year-over-year. Beverage Solutions grew nearly 17 percent. Single-serve cup volumes rose 9 percent, excluding volumes lost to a customer departure from industry consolidation. Management reported winning share across all categories.

The guidance the market is ignoring

Westrock reaffirmed its full-year 2026 adjusted EBITDA outlook of $90 million to $100 million. First-half EBITDA of $47.3 million came in roughly 10 percent ahead of internal plans, which means H2 needs to deliver roughly $43 million to $53 million to hit the range — comfortably below the H1 pace. Management called this a conservative posture. They intend to "crush" the current model and will provide 2027 numbers on the next call.

Here is the financial bridge: if 2026 EBITDA lands in the $90–100 million range and capex comes in near $30 million, free cash flow for the year could approach $60 million or more. If 2027 EBITDA continues to improve and capex drops toward the stated $15 million maintenance run rate, FCF generation could push into the $70–85 million range. That is a materially different business than the cash-burning builder the market priced through 2024 and early 2025.

Valuation

The stock sits at a market cap of roughly $710 million and enterprise value of $1.18 billion. EV-to-sales is 0.9 times — sub-1x revenue for a company growing sales in the mid-20s percentiles. If 2026 EBITDA hits $95 million midpoint, that implies an EV/EBITDA of roughly 12.5x. That is not cheap by tech standards, but it is in line with mid-single-digit-multiple industrial processors that aren't growing revenue at 24 percent.

The forward P/E is negative because the company is not yet profitable on a GAAP basis. That will not matter much once the balance sheet clears and net income follows EBITDA. Simple forward multiples beat DCF models here. If 2027 FCF runs $70–85 million and the market assigns a 10x multiple — a modest number for a business with that kind of leverage — the equity value sits in the $700 million to $950 million range. Current market cap is $710 million. There is room for a rerating if the cash-flow trajectory holds.

AInvest's aggregate signal still labels the stock a Buy, which is in line with the operating improvement even if the opaque scoring methodology gives no insight into the conviction behind the call.

The setup

This is not about dismissing the miss. The revenue fell short, gross profit declined, and the balance sheet still needs work. But the operating inflection — EBITDA acceleration meeting a collapsing capex curve — is the kind of structural shift that does not reverse in one quarter.

The market bar is lower now than it was six weeks ago. The stock has pulled back from its recent high. The full-year EBITDA guidance is conservative relative to H1 momentum. 2027 numbers coming on the next call could be the catalyst that forces a repricing.

What would break the thesis

Revenue growth falling below mid-single digits would suggest the share gains are fading. A re-acceleration of capex — anything back toward the $60 million range or higher — would undo the free-cash-flow story. Or a quarter where adjusted EBITDA decelerates, ending the five-quarter streak.

If any of those happen, the setup is broken. The inflection trade is built on a specific financial bridge, not optimism.

The condition to watch is simple: does H2 EBITDA stay on pace to hit the $90–100 million range while capex holds near $30 million? If yes, the bridge is intact and the miss was noise. If no, the thesis needs to be re-evaluated.

Discipline over ego.